002064 华峰化学
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入6,766,7217.17%24,198,21526,931,40726,298,46125,884,106
减:营业总成本5,972,9682.32%22,334,11124,617,26123,744,13422,830,706
    其中:营业成本5,517,7000.99%21,006,70923,205,47022,262,19221,242,019
               财务费用28,371-288.00%(44,357)(136,147)(145,582)(203,037)
               资产减值损失(9,221)--(11,456)(180,558)(51,693)(89,624)
公允价值变动收益7,666-33.15%18,2302,336(2,778)(2,342)
投资收益119,140246.94%212,524127,44593,504105,793
    其中:对联营企业和合营企业的投资收益15,472-44.84%65,54057,291100,71879,826
营业利润971,46468.14%2,368,6032,563,4242,768,0033,203,159
利润总额758,33633.91%2,133,7952,513,5942,618,8733,181,353
减:所得税费用88,88547.25%262,331286,760139,687339,412
净利润669,45132.32%1,871,4642,226,8342,479,1862,841,940
减:非控股权益828-48.58%13,9116,879721(2,032)
股东净利润668,62332.58%1,857,5532,219,9552,478,4642,843,972

市场价值指针
每股收益 (元) *0.13030.00%0.3700.4500.5000.580
每股派息 (元) *----0.1500.1500.1500.150
每股净资产 (元) *5.6333.66%5.5095.3315.0224.664
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容